Beyond diagnosis, periostin holds potential in guiding asthma phenotyping, helping identify patients with Th2-high inflammation who may benefit from targeted biologics (e.g., anti-IL-13 and anti-IL-4 receptor therapies) [16,17,18,19]. Here, IL13 is linked to asthma.